Evaxion Biotech Ownership
| EVAX Stock | USD 1.19 0.11 8.46% |
Shares in Circulation | First Issued 2019-12-31 | Previous Quarter 5.4 M | Current Value 5.5 M | Avarage Shares Outstanding 4.4 M | Quarterly Volatility 5.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Evaxion |
Evaxion Stock Ownership Analysis
About 25.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.8. Evaxion Biotech AS had not issued any dividends in recent years. The entity had 1:10 split on the 22nd of January 2024. Evaxion Biotech AS, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company was incorporated in 2008 and is headquartered in Hrsholm, Denmark. Evaxion Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people. To learn more about Evaxion Biotech AS call the company at 45 31 31 97 53 or check out https://www.evaxion-biotech.com.Evaxion Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Evaxion Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evaxion Biotech AS backward and forwards among themselves. Evaxion Biotech's institutional investor refers to the entity that pools money to purchase Evaxion Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Armistice Capital, Llc | 2024-09-30 | 483 K | Invst Llc | 2024-06-30 | 54 K | Citadel Advisors Llc | 2024-09-30 | 14.8 K | Beacon Capital Management, Llc | 2024-09-30 | 4.9 K | Jpmorgan Chase & Co | 2024-09-30 | 780 | Rhumbline Advisers | 2024-09-30 | 290 | Southstate Corp | 2024-09-30 | 4.0 | Tower Research Capital Llc | 2024-06-30 | 0.0 |
Evaxion Biotech Outstanding Bonds
Evaxion Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Evaxion Biotech AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Evaxion bonds can be classified according to their maturity, which is the date when Evaxion Biotech AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US29977LAA98 Corp BondUS29977LAA98 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US29977GAA04 Corp BondUS29977GAA04 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.